Advanced conventional chondrosarcomas: Time to revisit treatments and clinical research for what is not an indolent disease

Author： Italiano Antoine  

Publisher： Blackwell Publishing

E-ISSN： 1097-0142|120|20|3103-3104

ISSN： 0008-543X

Source： Cancer, Vol.120, Iss.20, 2014-10, pp. : 3103-3104

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

What Is an Epileptic Seizure? Unifying Definitions in Clinical Practice and Animal Research to Develop Novel Treatments

By D’Ambrosio Raimondo   Miller John W.  

Epilepsy Currents, Vol. 10, Iss. 3, 2010-05 ,pp. : 61-66

Blackwell Publishing

Access to resources Recommend Favorite

Disease Modifying Treatments for Multiple Sclerosis: What is on the Horizon?

By Weilbach F.X.   Gold R.  

CNS Drugs, Vol. 11, Iss. 2, 1999-02 ,pp. : 133-157

Adis International

Access to resources Recommend Favorite

Is it Time to Revisit the Current R&D Model?

By O'Connell Damian   Hopkins Andrew   Roblin David  

International Journal of Pharmaceutical Medicine, Vol. 21, Iss. 5, 2007-01 ,pp. : 339-345

Adis International

Access to resources Recommend Favorite

CD20-positive T-cell Lymphoma with Indolent Clinical Behaviour

By Xiao W-B   Wang Z-M   Wang L-J  

The Journal of International Medical Research, Vol. 38, Iss. 3, 2010-06 ,pp. : 1170-1174

Field House Publishing

Access to resources Recommend Favorite

Metastatic Thyroid Cancer Unresponsive to Conventional Therapies: Novel Management Approaches Through Translational Clinical Research

By  

Current Drug Targets - Immune, Endocrine & Metabolic Disorders, Vol. 1, Iss. 2, 2001-08 ,pp. : 103-115

Bentham Science Publishers

Access to resources Recommend Favorite